Home > Boards > US Listed > Biotechs > Acadia Pharmaceuticals Inc. (ACAD)

Uh oh, when the 1st infrastructure bill is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,659
Boards Moderated 1
Alias Born 08/16/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2021 5:34:13 PM
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - 9/2/2021 9:00:00 AM
Acadia Pharmaceuticals Announces Executive Leadership Change Business Wire - 9/1/2021 4:05:00 PM
Dermata therapeutics appoints Kyri Van Hoose as CFO Seeking Alpha - 9/1/2021 6:55:32 AM
Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021 Business Wire - 8/5/2021 4:05:00 PM
DRP Treatment’s Path Ahead Unclear, yet Current Risk/Reward Appears Favorable TipRanks - 8/5/2021 10:55:30 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 6:03:49 AM
ACADIA Pharma slides after 2021 guidance lagged expectations Seeking Alpha - 8/4/2021 5:03:42 PM
ACADIA Pharma EPS beats by $0.03, misses on revenue; FY21 guidance lowered Seeking Alpha - 8/4/2021 4:22:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2021 4:17:05 PM
Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results Business Wire - 8/4/2021 4:05:00 PM
The Street’s Gaze Turns to FDA Meeting’s Outcome on DRP Treatment TipRanks - 8/3/2021 7:30:30 PM
The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis Business Wire - 7/21/2021 5:05:00 PM
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Asso... Business Wire - 7/14/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2021 5:02:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:43:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:42:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:41:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:40:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2021 4:39:45 PM
NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders Business Wire - 6/3/2021 11:26:00 AM
NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders Business Wire - 6/3/2021 9:00:00 AM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 5/12/2021 4:22:37 PM
Acadia maintains 2021 sales guidance as Q1 net sales rise 18% Seeking Alpha - 5/5/2021 5:14:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 4:20:21 PM
gi197845   Tuesday, 08/10/21 09:02:31 AM
Re: None
Post # of 3045 
Uh oh, when the 1st infrastructure bill is passed today and then the 2nd, human infrastructure bill, it lowers prescription drug prices, thereby taking the profits out of pharma, thereby taking the profits away from pharma investors.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences